Effect of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastasis
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
It is the aim of this clinical study to evaluate the skeletal-related event rate and
tolerability of zoledronic acid in patients with prostate cancer patients and bone
metastases.